JPMorgan Chase & Co. Issues Positive Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price objective raised by JPMorgan Chase & Co. from $39.00 to $41.00 in a research note released on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other brokerages have also issued reports on SNDX. Scotiabank cut their […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price objective raised by JPMorgan Chase & Co. from $39.00 to $41.00 in a research note released on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other brokerages have also issued reports on SNDX. Scotiabank cut their […]
